One-year clinical outcomes of BioMatrix™-Biolimus A9™ eluting stent: The e-BioMatrix multicenter post marketing surveillance registry in India

One-year clinical outcomes of BioMatrix™-Biolimus A9™ eluting stent: The e-BioMatrix multicenter post marketing surveillance registry in India

Objective: The e-BioMatrix is a post marketing multicenter registry with an objective to evaluate the 2 year clinical safety and efficacy outcomes in patients treated with BioMatrix™ - Biolimus A9™ (BA9™) drug eluting stents (DES). Background: Drug-eluting stents still have late-stage disadvantages...

Full description

Bibliographic Details
Main Authors: Ashwin B. Mehta, Praveen Chandra, Jamshed Dalal, Prabhakar Shetty, Devang Desai, K. Chocklingam, Jayesh Prajapati, Pramod Kumar, Vilas Magarkar, Apurva Vasawada, B.K. Goyal, Viveka Kumar, V. Suryaprakash Rao, Ramesh Babu, Pritesh Parikh, Upendra Kaul, Aruna Patil, Tushar Mhetre, Hrishikesh Rangnekar
Format: Article
Language:English
Published: Elsevier 2013-09-01
Series:Indian Heart Journal
Subjects:
BioMatrix
BES
Biodegradable
MACE
Stent thrombosis
Online Access:http://www.sciencedirect.com/science/article/pii/S0019483213002848

Internet

http://www.sciencedirect.com/science/article/pii/S0019483213002848

Similar Items